MicroPort MedBot serves up inaugural profit on booming exports
The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the first half of 2026, reversing years of losses Key Takeaways: MicroPort…
BRIEF: MedBot revenue doubles in 2025 on strong overseas gains
Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) on Wednesday said it expects to report its revenue last year rose by 110% to 120% from 2024 on growing traction for its…
BRIEF: MedBot reports strong year-to-date sales as commercialization accelerates
Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) said on Wednesday that cumulative orders for its core products, including laparoscopic, orthopedic, and vascular intervention surgical robots, surpassed 170 units as of…
RELATED ARTICLES
-
Ubtech charms investors with companion robots – until reality sinks in
- Tiny income, big dreams: can True Health become the next robotics champion?
- INTERVIEW: Cainiao rolls out ZeeBot in latest step toward ‘Dark Warehouses’
- The new smart home: Where robots handle chores and provide companionship
-
Razor-thin margins slice holes in Leapmotor’s inaugural profit
9863.HK
- Dobot taps Shenzhen market to fund its bet on humanoid robots
